Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Covington Helps Secure Approval for GlaxoSmithKline's BCRs

June 26, 2013

LONDON, 26 June, 2013 — The UK Information Commissioner's Office has authorised GlaxoSmithKline’s 'Binding Corporate Rules' (BCRs) – a set of internal policies and procedures used to protect personal data across GSK’s operations globally. The privacy and data security team at Covington & Burling was instrumental in the development, implementation and authorisation of GSK’s BCRs.

GSK is one of the world’s leading research-based pharmaceutical and healthcare companies, with over 99,000 employees in over 100 countries. It is one of only 40 companies worldwide who have completed this rigorous process.

Binding Corporate Rules are designed to allow multinational companies to transfer personal data from the European Economic Area (EEA) to their affiliates located outside of the EEA. Applicants must demonstrate that their BCRs put in place adequate safeguards for protecting personal data throughout the organisation.

The Covington team was led by Dan Cooper, partner in the global privacy and data security practice, and senior associate Mark Young, and included policy analyst, Kristof Van Quathem.

Covington is widely recognised as a leading law firm in the global privacy and data security space with rankings in Chambers Global, Chambers UK, Chambers USA, Legal 500 UK, Legal 500 EMEA and Legal 500 USA.

Share this article: